GemPharmatech Co., Ltd.

SHSE:688046 Lagerbericht

Marktkapitalisierung: CN¥5.5b

GemPharmatech Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

GemPharmatech is forecast to grow earnings and revenue by 29% and 22% per annum respectively. EPS is expected to grow by 28.8% per annum. Return on equity is forecast to be 10.6% in 3 years.

Wichtige Informationen

29.0%

Wachstumsrate der Gewinne

28.8%

EPS-Wachstumsrate

Life Sciences Gewinnwachstum34.7%
Wachstumsrate der Einnahmen22.0%
Zukünftige Eigenkapitalrendite10.6%
Analystenabdeckung

Low

Zuletzt aktualisiert07 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

GemPharmatech's (SHSE:688046) Problems Go Beyond Weak Profit

Sep 10
GemPharmatech's (SHSE:688046) Problems Go Beyond Weak Profit

GemPharmatech (SHSE:688046) Seems To Use Debt Quite Sensibly

Jul 22
GemPharmatech (SHSE:688046) Seems To Use Debt Quite Sensibly

Some GemPharmatech Co., Ltd. (SHSE:688046) Shareholders Look For Exit As Shares Take 29% Pounding

Apr 16
Some GemPharmatech Co., Ltd. (SHSE:688046) Shareholders Look For Exit As Shares Take 29% Pounding

Gewinn- und Umsatzwachstumsprognosen

SHSE:688046 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CNY Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20261,1313021393525
12/31/2025943250562905
12/31/2024770202602475
9/30/2024677139-10164N/A
6/30/2024667158-14247N/A
3/31/2024639157-13678N/A
12/31/2023622159-89117N/A
9/30/2023585154-11696N/A
6/30/2023562161-107110N/A
3/31/2023541165-71118N/A
12/31/2022517165-84106N/A
9/30/2022500168-25122N/A
6/30/2022466160-16125N/A
3/31/2022433137-1496N/A
12/31/202139412524113N/A
12/31/202026276-37130N/A
12/31/2019193301965N/A
12/31/201853-64143N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 688046's forecast earnings growth (29% per year) is above the savings rate (2.9%).

Ertrag vs. Markt: 688046's earnings (29% per year) are forecast to grow faster than the CN market (25.8% per year).

Hohe Wachstumserträge: 688046's earnings are expected to grow significantly over the next 3 years.

Einnahmen vs. Markt: 688046's revenue (22% per year) is forecast to grow faster than the CN market (14% per year).

Hohe Wachstumseinnahmen: 688046's revenue (22% per year) is forecast to grow faster than 20% per year.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 688046's Return on Equity is forecast to be low in 3 years time (10.6%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y